What is the ALTITUDE-AD Study?

The ALTITUDE-AD Study is a clinical research study that will evaluate an investigational drug called ACU193. The study will test two different doses of the study drug against a placebo. (A placebo looks like the study drug, but it has no active ingredients.)

Who is eligible to participate?
Study participants must*
◆ be between 50 and 90 years old
◆ be experiencing memory loss or have a current diagnosis† of
■ mild cognitive impairment or
■ mild dementia due to Alzheimer’s disease
◆ have a study partner (such as a spouse, family member, or friend) who can attend study visits